BIO B
Bio-Rad Laboratories Inc - Class B (BIO-B)
Healthcare • NYSE • $255.54-2.19%
- Symbol
- BIO-B
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $255.54
- Daily Change
- -2.19%
- Market Cap
- $6.84B
- Trailing P/E
- 42.52
- Forward P/E
- N/A
- 52W High
- $321.12
- 52W Low
- $234.41
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 1.06
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharm…
Company websiteResearch BIO-B on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.